Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients
Status: Enrolling
Updated:  3/14/2017
NYU Langone Medical Center
mi
from
New York, NY
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients
Status: Enrolling
Updated: 3/14/2017
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
Status: Enrolling
Updated:  3/14/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation
Status: Enrolling
Updated: 3/14/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Placental Transfusion Project for Preterm Infants
Placental Transfusion in Preterm Infants Born at Less Than 34 Weeks of Gestation … Role of "Delayed" Cord Clamping and Umbilical Cord Milking
Status: Enrolling
Updated:  3/15/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Placental Transfusion Project for Preterm Infants
Placental Transfusion in Preterm Infants Born at Less Than 34 Weeks of Gestation … Role of "Delayed" Cord Clamping and Umbilical Cord Milking
Status: Enrolling
Updated: 3/15/2017
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated:  3/16/2017
Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital
mi
from
Boston, MA
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated: 3/16/2017
Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated:  3/16/2017
Otarukyokai Hospital
mi
from
Otaru,
Japanese National Computed Tomographic (CT) Colonography Trial
Evaluation of Accuracy of Computed Tomographic Colonography (CTC) in the Diagnosis of Colorectal Tumors by Gastroenterologists and Radiologists With Computer-aided Detection (CAD): A Multicenter Study
Status: Enrolling
Updated: 3/16/2017
Otarukyokai Hospital
mi
from
Otaru,
Click here to add this to my saved trials
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/16/2017
University of Miami / Clinical Research Services, Inc. Boynton Beach
mi
from
Miami, FL
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/16/2017
University of Miami / Clinical Research Services, Inc. Boynton Beach
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/16/2017
Orlando Clinical Research Center
mi
from
Orlando, FL
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/16/2017
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/16/2017
DaVita Clinical Research
mi
from
Minneapolis, MN
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single Dose, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of Osilodrostat (LCI699) in Subjects With Impaired Hepatic Function Compared to Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/16/2017
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Coronado, CA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Coronado, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Rialto, CA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Rialto, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Washington,
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Maitland, FL
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Maitland, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Miami, FL
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Zephyrhills, FL
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Rochester, NY
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Hershey, PA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Dallas, TX
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
San Antonio, TX
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Los Angeles, CA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
New Haven, CT
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
New Orleans, LA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Baltimore, MD
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Boston, MA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Detroit, MI
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Pittsburgh, PA
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Nashville, TN
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Fort Worth, TX
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated:  3/16/2017
Shionogi Research Site
mi
from
Buenos Aires,
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
Status: Enrolling
Updated: 3/16/2017
Shionogi Research Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids
Use of Diphenhydramine as an Adjunctive Sedative for Colonoscopy in Patients Chronically on Opioids
Status: Enrolling
Updated:  3/20/2017
Veterans Affairs Medical Center
mi
from
Oklahoma City, OK
Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids
Use of Diphenhydramine as an Adjunctive Sedative for Colonoscopy in Patients Chronically on Opioids
Status: Enrolling
Updated: 3/20/2017
Veterans Affairs Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated:  3/20/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated: 3/20/2017
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated:  3/20/2017
Medical University of South Carolina
mi
from
Charleston, SC
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated: 3/20/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated:  3/20/2017
Methodist Dallas Medical Center
mi
from
Dallas, TX
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated: 3/20/2017
Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated:  3/20/2017
Virginia Mason Medical Center
mi
from
Seattle, WA
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated: 3/20/2017
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated:  3/20/2017
Evangelisches Krankenhaus Dusseldorf
mi
from
Duesseldorf,
Short Term Pancreatic Stenting Registry
A Prospective Multi-Center Registry Using Plastic Pancreatic Stents for Short Term Drainage of the Pancreatic Duct
Status: Enrolling
Updated: 3/20/2017
Evangelisches Krankenhaus Dusseldorf
mi
from
Duesseldorf,
Click here to add this to my saved trials
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
An Open Label, Proof of Principle Study to Evaluate the Efficacy and Safety of Solithromycin for the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Status: Enrolling
Updated:  3/20/2017
Case Western University Hospitals
mi
from
Cleveland, OH
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
An Open Label, Proof of Principle Study to Evaluate the Efficacy and Safety of Solithromycin for the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Status: Enrolling
Updated: 3/20/2017
Case Western University Hospitals
mi
from
Cleveland, OH
Click here to add this to my saved trials
Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
Status: Enrolling
Updated:  3/21/2017
Cleveland Clinic
mi
from
Cleveland, OH
Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
Status: Enrolling
Updated: 3/21/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
New Bowel Preparation Scale for Measuring Colon Cleanliness
New Bowel Preparation Scale for Measuring the Cleansing of the Colon for Colonoscopy
Status: Enrolling
Updated:  3/23/2017
Gastroenterology Services
mi
from
Downers Grove, IL
New Bowel Preparation Scale for Measuring Colon Cleanliness
New Bowel Preparation Scale for Measuring the Cleansing of the Colon for Colonoscopy
Status: Enrolling
Updated: 3/23/2017
Gastroenterology Services
mi
from
Downers Grove, IL
Click here to add this to my saved trials
A Comparison of 5 Low Volume Bowel Preparations
A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy
Status: Enrolling
Updated:  3/23/2017
Gastroenterology Services
mi
from
Downers Grove, IL
A Comparison of 5 Low Volume Bowel Preparations
A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy
Status: Enrolling
Updated: 3/23/2017
Gastroenterology Services
mi
from
Downers Grove, IL
Click here to add this to my saved trials
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
Status: Enrolling
Updated:  3/27/2017
Baylor University Medical Center
mi
from
Dallas, TX
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
Status: Enrolling
Updated: 3/27/2017
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 101
mi
from
Detroit, MI
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 101
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 103
mi
from
Phoenix, AZ
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 103
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 108
mi
from
Coronado, CA
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 108
mi
from
Coronado, CA
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 903
mi
from
Durham, NC
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 903
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 910
mi
from
Dallas, TX
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 910
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 905
mi
from
San Antonio, TX
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 905
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 911
mi
from
Richmond, VA
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 911
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated:  3/27/2017
NGM Clinical Study Site 703
mi
from
Sydney,
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination With Ursodeoxycholic Acid (UDCA) Administered for 28 Days in Patients With Primary Biliary Cirrhosis
Status: Enrolling
Updated: 3/27/2017
NGM Clinical Study Site 703
mi
from
Sydney,
Click here to add this to my saved trials
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes in Inguinal Hernia Repair
Status: Enrolling
Updated:  3/27/2017
Progressive Surgical Associates/Silver Cross Hospital
mi
from
New Lenox, IL
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes in Inguinal Hernia Repair
Status: Enrolling
Updated: 3/27/2017
Progressive Surgical Associates/Silver Cross Hospital
mi
from
New Lenox, IL
Click here to add this to my saved trials
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes in Inguinal Hernia Repair
Status: Enrolling
Updated:  3/27/2017
Rochester General Hospital
mi
from
Rochester, NY
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes in Inguinal Hernia Repair
Status: Enrolling
Updated: 3/27/2017
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)
Acupuncture to Prevent Postoperative Paralytic Ileus
Status: Enrolling
Updated:  3/27/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)
Acupuncture to Prevent Postoperative Paralytic Ileus
Status: Enrolling
Updated: 3/27/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials